DADE (PAI-1) CHROMOGENIC ASSAY DADE COAGTROL-PAI— 510(k) K933188

Substantially Equivalent

Baxter Diagnostics, Inc.

FDA 510(k) clearance K933188 for DADE (PAI-1) CHROMOGENIC ASSAY DADE COAGTROL-PAI, Substantially Equivalent on 1993-09-22. Applicant: Baxter Diagnostics, Inc..

Clearance details

Applicant: Baxter Diagnostics, Inc.
Product code: Code JPA
Advisory panel: Hematology
Date received: 1993-06-30
Decision date: 1993-09-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JPA

product code JPA

Death: 6
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.